LORI SHUMAKER: Open Payments
NPI 1770230153 · SEVIERVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$883 in 54 payments from 17 companies in 2025. Trend: 2023 $1,069 · 2024 $1,309 · 2025 $883
Food & beverage: $883
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $261 |
| PFIZER INC. | 14 | $177 |
| ABBVIE INC. | 4 | $77 |
| Astellas Pharma US Inc | 2 | $56 |
| Dexcom, Inc. | 2 | $45 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $42 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Axsome Therapeutics, Inc. | 2 | $35 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
Products named: NURTEC ODT, Rybelsus, Ozempic, Wegovy, Veozah, VRAYLAR, Dexcom G6 Transmitter, JARDIANCE.
Industry payments across TN — which companies pay providers there.
